Ion Torrent

Ion Torrent, a wholly-owned subsidiary of Life Technologies, has pioneered an entirely new approach to sequencing that enables a direct connection between chemical and digital information. Ion Torrent™ technology doesn't use light—it's the first commercial PostLight™ sequencing technology.

Instead, Ion Torrent marries simple chemistry to incredibly powerful, proven semiconductor technology—it's Watson meets Moore. The result is a sequencing system that is simpler, faster, more cost effective and scalable than any other technology available. The company's goal is to democratize sequencing and make this critical technology available to every lab.

Ion Torrent headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $1.4B in funding across 24 round(s). With a team of 51-100 employees, Ion Torrent is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Ion Torrent, raised $37.1M. Discover more about their projects, partnerships, and impact on our platform.